Planet Labs vs Revolution Medicines Inc. Common Stock — how do they compare? Planet Labs trades at $16.73 (market cap $6.25B), while Revolution Medicines Inc. Common Stock trades at $191 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.5× Planet Labs's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Planet Labs for 4 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| PL | RVMD | |
|---|---|---|
Market Cap | $6.25B | $40.32B |
Volume | 19,125,340 | 4,855,734 |
Sector | Industrials | Health |
52-Week High | $51.40 | $221.15 |
52-Week Low | $11.16 | $47.50 |
Typical Hold Time | 4 Days | 0 Days |
Enterprise Value | $5.89B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →